What Adaptive Designs for Clinical Trials of Drugs and Biologics Guidance for Industry requires
This guidance provides recommendations for the use of adaptive designs in clinical trials, as outlined in Section III…
This is a preview. The full record adds the complete summary, 10 workflow steps, 8 schema fields and 9 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: U.S. Food and Drug Administration · Version: 1.0.1 · Last updated:
Primary source: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/adaptive-design-clinical-trials-drugs-and-biologics
SHA-256 integrity: 199d0256d3900194586ca35e8ddf18e3ddd7f79695ce11f5150873c9b98e98a5
Primary Citations — 9 traced to source
- Section I: Introduction
- Section III: Pre-Specified Adaptations
+ 7 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/fda-adaptive-clinical-trial-design-guidance-2019.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/fda-adaptive-clinical-trial-design-guidance-2019.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/fda-adaptive-clinical-trial-design-guidance-2019
- Back to registry: Browse all 10,102 compliance nodes